ERPR Breast Disease Early Stage, Locally Advanced and Metastatic Breast Cancer
By: Vicente Valero, MD, FACP
Chemotherapy and Hormonal Therapy in the Metastatic Setting, ER+ HER2-2- and TNBC
By: Vicente Valero, MD, FACP
ER-PR Breast Disease - Early Stage, LocallyAdvanced and Metastatic Breast Cancer
By: Vicente Valero, MD, FACP
ER/PR Breast Disease: Early Stage, Locally Advanced and Metastatic Breast Cancer
By: Vicente Valero, MD, FACP
ER/PR and CDK Pathways in the Management of ER+ Metastatic Breast Cancer
By: Vicente Valero, MD, FACP
Breast Cancer Session
By: Vicente Valero, MD; Luis Baez Vallecillo, MD; Noridza Rivera-Rodriguez, MD; Mariana Chavez-MacGregor, MD; Mohammad Jahanzeb, MD, FACP, FASCO
Optimal Treatment for Early Stage HER2 Positive Breast Cancer: Tailoring Treatment to Response
By: Virginia Borges, MD
Optimal Treatment for Early Stage HER2 Positive Breast Cancer: Tailoring Treatment to Response
By: Virginia Borges, MD
Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer
By: William J. Gradishar, MD, FACP
Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer
By: William J. Gradishar, MD, FACP
Advances in the Treatment of High Risk Early Stage Hormone Receptor Positive Breast Cancer
By: William J. Gradishar, MD, FASCO, FACP
